Printer Friendly

COMPANY INFORMATION
Neptune Technologies & Bioressources inc. 200-225 prom du Centropolis Laval, QC H7T 3B3 Tel: (450) 687-2262 Toll-free: (888) 664-9166 Fax: (450) 687-2272 Contact Name Xavier Harland Industry Pharmaceuticals		Key Executives Henri Harland, CEO André Godin, v-p, fin. & admin. Formulates and produces science-based and clinically proven phospholipid products for the nutraceutical and pharmaceutical markets.
FP ADVISOR COVERAGE Neptune Technologies & Bioressources inc. • FP Corporate Analyzer • FP Directory of Directors • FP Corporate Surveys • Ordering FP Products		TOP INDUSTRY PLAYERS Pharmaceuticals Company Name Revenue ($000s)  Biovail Corporation 936,111 Patheon Inc. 765,812 Cangene Corporation 238,751 Paladin Labs Inc. 109,693 Cardiome Pharma Corp. 54,672 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF SEPT. 8/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX-VEN/NTB NASDAQ/NEPT $1.77 $2.58 on Nov. 16/09 $1.02 on July 5/10 n.a. n.a. n.a. 1.42 Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap (000s) 23,504 n.a. $0.01 May 31/10 -20.98% -27.32% 51.74% $71,106
ANNUAL FINANCIALS Periods ended: 12m Feb. 28/10 9m Feb. 28/09 12m May 31/08 $000s $000s $000s Operating revenue 12,664 8,589 10,264 Net income (1,535) (1,889) (4,785) Total assets 17,566 18,301 14,357 $ $ $ Earnings per share* (0.04) (0.05) (0.13) % % % Return on equity (17.91) ... (60.55)   * Common
TRAILING 12-MONTH VALUES Periods ended: May 31/10 May 31/09 $000s $000s Operating revenue 13,948 11,467 Net income 348 (3,296) $ $ Earnings per share 0.00 (0.09)

COMPANY NEWS

Results for 'Neptune Technologies & Bioressources inc.' from past 30 days: No hits. (Links are to articles.)